266 related articles for article (PubMed ID: 19212960)
1. Cyclic RGD-containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting.
Manzoni L; Belvisi L; Arosio D; Civera M; Pilkington-Miksa M; Potenza D; Caprini A; Araldi EM; Monferini E; Mancino M; Podestà F; Scolastico C
ChemMedChem; 2009 Apr; 4(4):615-32. PubMed ID: 19212960
[TBL] [Abstract][Full Text] [Related]
2. A potent integrin antagonist from a small library of cyclic RGD pentapeptide mimics including benzyl-substituted azabicycloalkane amino acids.
Arosio D; Belvisi L; Colombo L; Colombo M; Invernizzi D; Manzoni L; Potenza D; Serra M; Castorina M; Pisano C; Scolastico C
ChemMedChem; 2008 Oct; 3(10):1589-603. PubMed ID: 18770516
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and NMR structure of peptidomimetic alpha4beta7-integrin antagonists.
Gottschling D; Boer J; Marinelli L; Voll G; Haupt M; Schuster A; Holzmann B; Kessler H
Chembiochem; 2002 Jun; 3(6):575-8. PubMed ID: 12325015
[No Abstract] [Full Text] [Related]
4. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands.
Marchini M; Mingozzi M; Colombo R; Guzzetti I; Belvisi L; Vasile F; Potenza D; Piarulli U; Arosio D; Gennari C
Chemistry; 2012 May; 18(20):6195-207. PubMed ID: 22517378
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biochemical evaluation of a cyclic RGD oxorhenium complex as new ligand of alphaVbeta3 integrin.
Aufort M; Gonera M; Chaignon N; Le Clainche L; Dugave C
Eur J Med Chem; 2009 Sep; 44(9):3394-401. PubMed ID: 19303174
[TBL] [Abstract][Full Text] [Related]
6. Cyclic aza-peptide integrin ligand synthesis and biological activity.
Spiegel J; Mas-Moruno C; Kessler H; Lubell WD
J Org Chem; 2012 Jun; 77(12):5271-8. PubMed ID: 22582818
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic effect of dual/selective alpha(5)beta(1)/alpha(v)beta(3) integrin antagonists designed on partially modified retro-inverso cyclotetrapeptide mimetics.
Gentilucci L; Cardillo G; Spampinato S; Tolomelli A; Squassabia F; De Marco R; Bedini A; Baiula M; Belvisi L; Civera M
J Med Chem; 2010 Jan; 53(1):106-18. PubMed ID: 20055426
[TBL] [Abstract][Full Text] [Related]
8. Functionalized cyclic RGD peptidomimetics: conjugable ligands for αvβ3 receptor imaging.
Arosio D; Manzoni L; Araldi EM; Caprini A; Monferini E; Scolastico C
Bioconjug Chem; 2009 Aug; 20(8):1611-7. PubMed ID: 21141806
[TBL] [Abstract][Full Text] [Related]
9. Cyclic DGR-peptidomimetic containing a bicyclic reverse turn inducer as a selective alpha(v)beta (5) integrin ligand.
Trabocchi A; Menchi G; Danieli E; Potenza D; Cini N; Bottoncetti A; Raspanti S; Pupi A; Guarna A
Amino Acids; 2010 Jan; 38(1):329-37. PubMed ID: 19267182
[TBL] [Abstract][Full Text] [Related]
10. Novel potent and selective alphavbeta3/alphavbeta5 integrin dual antagonists with reduced binding affinity for human serum albumin.
Raboisson P; Manthey CL; Chaikin M; Lattanze J; Crysler C; Leonard K; Pan W; Tomczuk BE; Marugán JJ
Eur J Med Chem; 2006 Jul; 41(7):847-61. PubMed ID: 16697080
[TBL] [Abstract][Full Text] [Related]
11. Biselectivity of isoDGR peptides for fibronectin binding integrin subtypes α5β1 and αvβ6: conformational control through flanking amino acids.
Bochen A; Marelli UK; Otto E; Pallarola D; Mas-Moruno C; Di Leva FS; Boehm H; Spatz JP; Novellino E; Kessler H; Marinelli L
J Med Chem; 2013 Feb; 56(4):1509-19. PubMed ID: 23362923
[TBL] [Abstract][Full Text] [Related]
12. Cyclic RGD functionalized gold nanoparticles for tumor targeting.
Arosio D; Manzoni L; Araldi EM; Scolastico C
Bioconjug Chem; 2011 Apr; 22(4):664-72. PubMed ID: 21434651
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of novel cRGD-paclitaxel conjugates for integrin-assisted drug delivery.
Pilkington-Miksa M; Arosio D; Battistini L; Belvisi L; De Matteo M; Vasile F; Burreddu P; Carta P; Rassu G; Perego P; Carenini N; Zunino F; De Cesare M; Castiglioni V; Scanziani E; Scolastico C; Casiraghi G; Zanardi F; Manzoni L
Bioconjug Chem; 2012 Aug; 23(8):1610-22. PubMed ID: 22770429
[TBL] [Abstract][Full Text] [Related]
14. N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists.
Dechantsreiter MA; Planker E; Mathä B; Lohof E; Hölzemann G; Jonczyk A; Goodman SL; Kessler H
J Med Chem; 1999 Aug; 42(16):3033-40. PubMed ID: 10447947
[TBL] [Abstract][Full Text] [Related]
15. Phage peptide display.
Newton J; Deutscher SL
Handb Exp Pharmacol; 2008; (185 Pt 2):145-63. PubMed ID: 18626602
[TBL] [Abstract][Full Text] [Related]
16. Interest of RGD-containing linear or cyclic peptide targeted tetraphenylchlorin as novel photosensitizers for selective photodynamic activity.
Frochot C; Di Stasio B; Vanderesse R; Belgy MJ; Dodeller M; Guillemin F; Viriot ML; Barberi-Heyob M
Bioorg Chem; 2007 Jun; 35(3):205-20. PubMed ID: 17223161
[TBL] [Abstract][Full Text] [Related]
17. Targeting integrins: insights into structure and activity of cyclic RGD pentapeptide mimics containing azabicycloalkane amino acids.
Belvisi L; Bernardi A; Colombo M; Manzoni L; Potenza D; Scolastico C; Giannini G; Marcellini M; Riccioni T; Castorina M; LoGiudice P; Pisano C
Bioorg Med Chem; 2006 Jan; 14(1):169-80. PubMed ID: 16214345
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and conformational analysis of cyclotetrapeptide mimetic beta-turn templates and validation as 3D scaffolds.
Gentilucci L; Cardillo G; Tolomelli A; De Marco R; Garelli A; Spampinato S; Spartà A; Juaristi E
ChemMedChem; 2009 Apr; 4(4):517-23. PubMed ID: 19226499
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship studies of targeting ligands against breast cancer cells.
Yao N; Xiao W; Meza L; Tseng H; Chuck M; Lam KS
J Med Chem; 2009 Nov; 52(21):6744-51. PubMed ID: 19835381
[TBL] [Abstract][Full Text] [Related]
20. Aza-bicyclic amino acid carboxamides as alpha4beta1/alpha4beta7 integrin receptor antagonists.
Dyatkin AB; Gong Y; Miskowski TA; Kimball ES; Prouty SM; Fisher MC; Santulli RJ; Schneider CR; Wallace NH; Hornby PJ; Diamond C; Kinney WA; Maryanoff BE; Damiano BP; He W
Bioorg Med Chem; 2005 Dec; 13(24):6693-702. PubMed ID: 16112583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
